News
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Eckert & Ziegler and Telix Pharmaceuticals Enter into a Collaboration and Licence Agreement for Actinium-225
Eckert & Ziegler SE signs collaboration and license agreement with Telix Pharmaceuticals for Ac-225 production, aiming to become a major supplier in the radiopharmaceutical industry -
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Eckert & Ziegler Again Increases Sales and Earnings in the First Nine Months Compared to Previous Year
Eckert & Ziegler SE reports increased sales and earnings in the first nine months of 2024 compared to previous year. Strong performance indicated by sales of EUR 215.5 million and EBIT of EUR 46.7 million -
